Clinical Trial Site

Busan 49241

3 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Advanced Hepatocellular Carcinoma, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Metastatic Breast Cancer, Metastatic Hepatocellular Carcinoma

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now